Description

Sermorelin Acetate 5mg × 10 vials

A synthetic growth hormone-releasing hormone analogue studied for growth hormone signaling, pituitary response, IGF-1-related pathways, endocrine research, and broader growth hormone support protocols.

Product Overview

Compound: Sermorelin Acetate
Strength: 5 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

Sermorelin Acetate is described as a synthetic analogue of growth hormone-releasing hormone, also known as GHRH 1-29. It has been studied for pituitary growth hormone release, growth hormone deficiency research, IGF-1 response, and endocrine signaling pathways.

No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.